Open·Ingested 46 days ago, not re-verified since

DoW Duchenne Muscular Dystrophy, Clinical/Translational Research Award

Defense Health Agency Contracting Activity - DHACA

Go to the official application

Free. Verify your email, then we send one reminder only.

Download details (file)

Posted: Jun 17, 2026
Amount: $8,460,000
Closes: Sep 18, 2026 (in 47 days)

Similar opportunities open now

DoW Duchenne Muscular Dystrophy, Idea Development AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 47 days
DoW Spinal Cord Injury, Clinical Translation Research AwardOpenDefense Health Agency Contracting Activity - DHACACloses Nov 2026
DOW Combat Readiness – Medical Research Program Translational Research AwardOpenDefense Health Agency Contracting Activity - DHACACloses Nov 2026
DoW Alzheimer’s Transforming Care AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 53 days
DoW Alzheimer’s Transforming Research AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 53 days

Classification and identifiers

Solicitation number: HT942526DMDRPCTRA
Assistance listing (CFDA): 12.420

Amount

$8,460,000

Who can apply

Open to all

About this opportunity

Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Clinical/Translational Research Award (CTRA) supports advanced translational research to accelerate promising ideas in Duchenne muscular dystrophy (DMD) research toward clinical applications. Research must address at least one of the FY26 CTRA Focus Areas. Research projects investigating therapies that will be efficacious across the life span are strongly encouraged. Distinctive Features: The FY26 CTRA offers two funding levels: • Funding Level 1 to support smaller, less complex preclinical and/or clinical research. • Funding Level 2 to support larger, more complex preclinical and/or clinical research. The FY26 CTRA also offers a Partnering PI Option (PPIO) to support meaningful and productive partner...